Health Technology, Healthcare Analytics

Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity

Capital Rx Launches Rx Reverse

Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) reversal leader Virta Health have partnered to introduce Rx Reverse. Available to all of Capital Rx's customers, Rx Reverse is a high-touch, provider-led, integrated clinical program designed to help members reverse T2D and fight obesity without costly medications.

The problem is clear: 37+ million Americans have been diagnosed with diabetes, and over 90% of them have T2D (including one-third of the population over 65 years old).1 At the same time, the prevalence of obesity is over 40% of the U.S. population2 and is expected to reach nearly 50% by 2030.3 During a June 15, 2023 webinar, Rethinking Obesity Strategies: The Rise of GLP-1 Drugs and Lifestyle Programs for Weight Loss, Virta revealed new survey data highlighting that diabetes and obesity are the #1 and #2 concerns of health plan leaders in 2023 because of rising costs and downstream health impact.

The launch of Rx Reverse comes as demand for GLP-1 drugs approved for diabetes and weight loss is rising rapidly, and employers and health plan leaders focus on managing the cost of diabetes and obesity. Rx Reverse combines Capital Rx's tech-enabled pharmacy benefit management (PBM) service model, powered by JUDI®, and Virta's solution – personalized nutrition therapy, physician-led deprescription, remote monitoring, and one-on-one coaching – to help health plans reduce costs and improve members' health.

"Leveraging JUDI, our proprietary next-generation claim adjudication platform for Medicare, Medicaid, and commercial plans, we have the ability to seamlessly connect with vendors like Virta, sharing actionable member information efficiently in real-time, and providing the connectivity plan members need to improve their overall health," said Sara Izadi, PharmD, Senior Vice President of Pharmacy at Capital Rx. "Our Single-Ledger Model™, coupled with JUDI's capabilities, enables us to partner with Virta on a solution focused on deprescribing and health equity."

Virta reports lowering HbA1c for patients by 1.3% on average after one year, and 60% of patients enrolled one year attained an HbA1c below 6.5% without using diabetes medications other than metformin. Moreover, patients experience an average of 12% body weight loss at two years. And like Capital Rx, which saves payers 10% - 30% in the first year, on average, after switching from a traditional PBM model, Virta emphasizes positive financial outcomes, including demonstrating an estimated $503 per engaged member per month gross savings for T2D reversal participants.

Three Rx Reverse options are available for plan sponsors to choose from

  • Type 2 Diabetes Reversal: Helps plan members achieve lower blood sugar – often to sub-diabetes levels <6.5 A1c – and clinically significant weight loss alongside safe deprescription of diabetes medication.
  • Provider-Led Weight Loss: Helps plan members without diabetes who are considered overweight (BMI ≥ 25) or obese (BMI ≥ 30) achieve clinically significant weight loss.
  • Type 2 Diabetes Reversal & Provider-Led Weight Loss

"The rapidly rising utilization and cost of obesity and diabetes drugs is putting extreme pressure on healthcare payers," said Kevin Kumler, President at Virta Health. "Capital Rx's tech-forward, value-based approach – a needed evolution from the traditional PBM model – aligns both incentives and systems to help payers control drug costs while members get healthier."

About Virta Health

Virta Health is the leader in type 2 diabetes reversal and is creating a new standard in medical care for people living with type 2 diabetes, prediabetes, or obesity. The company's virtual approach combines personalized nutrition therapy with continuous provider-led support to empower members to eliminate medications, lose weight, and take back their lives. Virta has earned the trust of the nation's largest organizations, including Humana, AutoZone, and Blue Shield of California, delivering industry-leading cost savings of over $6,000 per member per year while putting our fees at risk based on health outcomes.

About Capital Rx

Capital Rx is a healthcare technology company changing the way prescription drugs are priced and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single-Ledger Model™, the industry's first ethical framework for drug pricing. The company's cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem, servicing over 2.4 million members for Medicare, Medicaid, and commercial plans.

Spotlight

Spotlight

Related News

Health Technology

Alameda Healthcare Group and Medtronic Unveil Neuroscience Center

Medtronic | November 08, 2023

Alameda Healthcare Group, in partnership with Medtronic, has launched a Neuroscience Center of Excellence to enhance patient care in Egypt and nearby areas. This initiative introduces the StealthStation S8 Surgical Navigation System to revolutionize surgical procedures and enhance clinical outcomes. The Alameda-Medtronic partnership is set to enhance patient care, aligning with Alameda's mission to improve healthcare and solidifying its pioneering role. Alameda Healthcare Group, a premier private healthcare service provider in Egypt, has announced the inauguration of its Neuroscience Center of Excellence, a collaborative effort with Medtronic, a renowned leader in healthcare technology solutions. At the inauguration of the Neuroscience Center of Excellence, esteemed speakers elaborated on the significant role anticipated for the StealthStation S8 Surgical Navigation System in advancing the field of neurosurgery. Meanwhile, Dr. Ramy Amin, Professor of Neurosurgery at Cairo University, led a panel discussion during the launch event. The panel also featured some of the renowned medical consultants, leading neurosurgeons, as well as neurologists. Additionally, Professor Hossam Salah, the Dean of the Faculty of Medicine at Cairo University, graced the event as the guest of honor. The panel discussion explored the pivotal role that this new center is poised to play in enhancing key aspects of neurosurgery. It also commended Alameda's dedication to elevating the quality of patient care through the integration of innovative technology. Neeraj Mishra, Group CEO of Alameda Healthcare, remarked. This partnership represents a substantial step forward in setting new standards for healthcare excellence in Egypt, and we look forward to the benefits it will bring to the patients Alameda continues to serve. [Source – Zawya] He also stated that establishing the Neuroscience Center of Excellence shows Alameda's commitment to advancing technology and raising healthcare standards in Egypt and the surrounding region. With this strategic partnership, Alameda Healthcare Group can incorporate Medtronic's advanced technology into its new center of excellence, thereby bringing about a substantial enhancement in surgical procedures and ultimately improving patient outcomes. Through real-time tracking and advanced imaging capabilities, this technology will enable neurosurgeons to steer complex surgical procedures with heightened precision, thereby enhancing patient results. It will also provide surgeons with various advanced features, including precise imaging, guidance, and different essential surgical tools. The partnership between Alameda Healthcare Group and Medtronic will provide patients with advanced, precise, and patient-focused surgical care. This perfectly aligns with Alameda's mission to improve healthcare for everyone, reinforcing its position as a pioneer in the healthcare industry.

Read More

Health Technology

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals

PR Newswire | November 03, 2023

DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring. "Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont." By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes. Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch. [Source: PR Newswire] Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives. ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days. DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities. The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring. The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable. DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion. As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37. DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance. Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.

Read More

Healthcare Analytics

Maxim Healthcare Services Names National Caregiver of the Year

Business Wire | September 29, 2023

Barbara Buttchen has been named National Caregiver of the Year by Maxim Healthcare Services (Maxim), a national provider of home healthcare, personal and behavioral care. Buttchen, a nurse in Maxim’s Madison, Wisconsin office was presented with the John “Doc” Langley National Caregiver of the Year award alongside colleagues and fellow nominees during a ceremony in Baltimore, Maryland on September 19. “Barbara makes such a difference in the lives of her patients and their families every day,” said Maxim’s Chief Executive Officer, Jarrod DePriest. We deeply admire Barbara’s dedication to providing quality compassionate in-home care and we are thrilled to present her with this much-deserved recognition. [Source – Business Wire] Selected by a panel of judges for her impactful contributions to the home healthcare community, Buttchen has worked as a nurse for more than 50 years. Described by her colleagues as one of the most selfless, caring, kind, and hard-working individuals, Buttchen prioritizes others’ well-being more than her own. She currently lives with lymphoma but keeps a positive attitude and is always looking for ways to serve others. She extends caregiving to her personal life with activities such as delivering Meals on Wheels to individuals in need, providing care to a friend that has Alzheimer's, and also lending her expertise to a friend’s husband that is wheelchair bound while they travel, so that the vacation can be safe and enjoyable. During the ceremony Barbara shared, “I wanted to be like Florence Nightingale. That’s how I want to be known and live my life. Before I lay my head down on the pillow, I want to make rounds one more time, with the lantern, to see if there’s someone that needs my care. Thank you so much for this honor.” Maxim’s Caregiver of the Year Award Program, which is celebrated annually, recognizes the nurses, home healthcare aides and behavioral direct care workers who all play a vital role in providing compassionate, holistic care for patients who are both medically fragile and who require behavioral and community support. Learn more about Buttchen’s story, here. In addition to honoring Buttchen, Maxim also celebrates another significant milestone this year – providing 35 years of compassionate, holistic home healthcare for patients. DePriest, who has been with Maxim since 1998 and first started with the company as a healthcare recruiter, lauds the Maxim team for this accomplishment. “The healthcare industry has continued to rapidly grow and evolve, and likewise so has Maxim,” said DePriest. “As a mission-driven company, we are passionate about our work and improving the lives of our patients, their families and the communities we serve nationwide. I want to thank our exceptional team for their commitment and service, and to our patients and their families that have welcomed us into their homes.”

Read More